Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2019 | Anti-leukemia and anti-viral T-cell immunotherapy of photodepleted allogeneic T-cells

Denis-Claude Roy • 24 Mar 2019
EBMT 2019
General ATIR101

Denis-Claude Roy, MD, FRCPC, from the University of Montreal, Montreal, Canada, speaks about potential methods to minimize the occurance of graft-versus-host disease (GvHD) using anti-leukemia and anti-viral T-cell immunotherapy of photodepleted allogeneic T-cells. This interview took place at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

More from Denis-Claude Roy

ATIR101 after haplo HSCT proves promising
3:25
ATIR101 after haplo HSCT proves promising
Denis-Claude Roy • 7 Dec 2019
T-cell depleted haploidentical SCT followed by ATIR101 vs. T-cell replete HSCT plus chemo
1:42
T-cell depleted haploidentical SCT followed by ATIR101 vs. T-cell replete HSCT plus chemo
Denis-Claude Roy • 24 Mar 2019
Eradicating GvHD after haploidentical stem cell transplant
2:08
Eradicating GvHD after haploidentical stem cell transplant
Denis-Claude Roy • 18 Mar 2018
Implications for a technique which eliminates GvHD
1:56
Implications for a technique which eliminates GvHD
Denis-Claude Roy • 18 Mar 2018

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals